Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Hsia

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Transfusion|June 12, 2024
Current state of undergraduate medical school training in transfusion medicine and its impact on postgraduate trainee knowledgeMahboubeh Rahmani, Sophie Chargé, Melanie Bodnar, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Transfusion|September 25, 2015
Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopeniaMichelle P Zeller, Nancy M Heddle, John G Kelton, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Vox Sanguinis|September 14, 2022
Plasma transfusion practices: A multicentre electronic auditAditi Khandelwal, Leigh Minuk, Yang Liu, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
European Journal of Haematology|June 10, 2019
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignanciesMichael A Levy, Stephanie Santos, Jennifer Kerkhof, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Transfusion|June 12, 2024
Current state of undergraduate medical school training in transfusion medicine and its impact on postgraduate trainee knowledgeMahboubeh Rahmani, Sophie Chargé, Melanie Bodnar, et al.
CMAJ Open|November 8, 2022
Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart reviewBenjamin Chin-Yee, Maxim Matyashin, Ian Cheong, et al.
Transfusion|September 25, 2015
Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopeniaMichelle P Zeller, Nancy M Heddle, John G Kelton, et al.
JCO Oncology Practice|June 3, 2025
Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement ProjectJenny M Ho, Uday Deotare, Aatif Qureshi, et al.
Vox Sanguinis|September 14, 2022
Plasma transfusion practices: A multicentre electronic auditAditi Khandelwal, Leigh Minuk, Yang Liu, et al.
Blood Advances|November 15, 2021
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopeniaManraj N Kaur, Donald M Arnold, Nancy M Heddle, et al.
Thrombosis and Haemostasis|January 28, 2019
Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and RationaleDonald M Arnold, Erin Jamula, Nancy M Heddle, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2024
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in CanadaJoanne Britto, Anne Holbrook, Haowei Sun, et al.
The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.
European Journal of Haematology|June 10, 2019
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignanciesMichael A Levy, Stephanie Santos, Jennifer Kerkhof, et al.
Pageof 3